BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/21/2022 8:16:14 AM | Browse: 818 | Download: 1837
 |
Received |
|
2021-05-03 10:39 |
|
Peer-Review Started |
|
2021-05-03 10:43 |
|
First Decision by Editorial Office Director |
|
2021-06-15 21:49 |
|
Return for Revision |
|
2021-06-15 21:49 |
|
Revised |
|
2021-06-18 04:12 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-12-09 03:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-12-10 03:11 |
|
Articles in Press |
|
2021-12-10 03:11 |
|
Edit the Manuscript by Language Editor |
|
2021-12-07 10:40 |
|
Typeset the Manuscript |
|
2022-01-18 04:33 |
|
Publish the Manuscript Online |
|
2022-01-21 08:16 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemistry & Molecular Biology |
| Manuscript Type |
Minireviews |
| Article Title |
Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Shanmugam Murugaiha Jeyakumar and Ayyalasomayajula Vajreswari |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Indian Council of Medical Research (ICMR) |
5/4/3-10/TF/2011/NCD-II |
| Department of Biotechnology (DBT) |
BT/PR6145/FNS/20/566/2012 |
| ICMR-NIN-Intramural Gran |
|
|
| Corresponding Author |
Shanmugam Murugaiha Jeyakumar, PhD, Senior Scientist, Department of Clinical Pharmacology, National Institute for Research in Tuberculosis, No. 1 Mayor Sathiyamoorthy Road, Chetpet, Chennai 600031, Tamil Nadu, India. smjkumar@gmail.com |
| Key Words |
Steatosis; Lipids; Fatty acids; Vitamin A; Metabolic syndrome; Obesity |
| Core Tip |
Stearoyl-CoA desaturase 1 (SCD1) is the rate-limiting enzyme of the monounsaturated fatty acids biosynthesis that serves as substrates for de novo lipogenesis, thereby increasing the production and accumulation of triglycerides in the liver. The liver-specific inhibition of SCD1 has been shown to attenuate the development of hepatic steatosis and thus non-alcoholic fatty liver disease (NAFLD), as evidenced by experimental studies. The current evidence supports the view that SCD1 is a potential target and the inhibition of this enzyme would certainly help in the control and/or management of NAFLD in humans. However, certain aspects of SCD1 such as its role and regulation need to be addressed in humans to explore its potential translational applicability. |
| Publish Date |
2022-01-21 08:16 |
| Citation |
Jeyakumar SM, Vajreswari A. Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence. World J Hepatol 2022; 14(1): 168-179 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i1/168.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i1.168 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
